Drug or technology
5 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
JUN 18, 2026 · REGULATORY LABEL UPDATE
U.S. Food and Drug Administration
FDA supplemental approval for methadone hydrochloride REMS; establishes regulatory requirements but does not report clinical trial outcomes or efficacy evidence.
JUN 18, 2026 · REGULATORY LABEL UPDATE
U.S. Food and Drug Administration
FDA supplemental approval action for methadone hydrochloride REMS; regulatory designation only, not a clinical evidence assessment.
JUN 18, 2026 · REGULATORY LABEL UPDATE
U.S. Food and Drug Administration
FDA supplemental approval action for methadone hydrochloride REMS; regulatory classification, not efficacy evidence.
JUN 18, 2026 · REGULATORY LABEL UPDATE
U.S. Food and Drug Administration
FDA supplemental approval of methadone hydrochloride under REMS, a regulatory action affecting drug access and safety monitoring requirements, not a clinical efficacy study.
JUN 18, 2026 · REGULATORY LABEL UPDATE
U.S. Food and Drug Administration
FDA supplemental approval of methadone hydrochloride REMS establishes risk management requirements; does not report clinical trial efficacy or comparative outcomes.